| 201 |
12086293 | Current perspective on the cardiovascular effects of coxibs. | 2002 |
1 |
| 202 |
12391014 | Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. | 2002 Oct 21 |
4 |
| 203 |
12395741 | [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions]. | 2002 Sep 28 |
2 |
| 204 |
12423318 | COX-2-independent antiproliferative action of acetylsalicylic acid in human colon cancer cells. | 2002 Nov |
1 |
| 205 |
12456256 | Aspirin use may change cost-effectiveness of COX-2 inhibitors. | 2002 Dec 9-23 |
1 |
| 206 |
12512737 | Gastrointestinal safety of low-dose aspirin. | 2002 Dec |
1 |
| 207 |
14561202 | Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis. | 2002 Mar |
1 |
| 208 |
24728118 | [Not Available]. | 2002 Sep |
1 |
| 209 |
11173047 | Cyclooxygenase inhibition and thrombogenicity. | 2001 Feb 19 |
1 |
| 210 |
11235048 | Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma. | 2001 Feb |
2 |
| 211 |
11251623 | Safety of a specific COX-2 inhibitor in aspirin-induced asthma. | 2001 Feb |
2 |
| 212 |
11266647 | Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. | 2001 Mar 15 |
1 |
| 213 |
11437671 | Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. | 2001 |
1 |
| 214 |
11552047 | Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. | 2001 |
1 |
| 215 |
11566042 | COX-1 and COX-2 inhibitors. | 2001 Oct |
2 |
| 216 |
11577463 | [Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors]. | 2001 Sep |
3 |
| 217 |
11695246 | What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. | 2001 Nov-Dec |
1 |
| 218 |
11717412 | A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. | 2001 Dec 4 |
1 |
| 219 |
11742186 | Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. | 2001 Dec |
1 |
| 220 |
12120179 | One hundred years of NSAID gastropathy: are coxibs the answer? | 2001 |
1 |
| 221 |
10671506 | Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin-treated cyclooxygenase-2. Implications for the alignment of substrate in the active site. | 2000 Feb 18 |
2 |
| 222 |
10868686 | Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. | 2000 Jun |
2 |
| 223 |
10942685 | Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. | 2000 Aug |
1 |
| 224 |
10977131 | Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen. | 2000 Aug |
1 |
| 225 |
10992560 | The importance of COX-2 inhibition for aspirin induced asthma. | 2000 Oct |
1 |
| 226 |
11055820 | COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs. | 2000 |
1 |
| 227 |
11078056 | Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. | 2000 Oct |
1 |
| 228 |
11211927 | Assay of cyclooxygenase-1 and 2 in human monocytes. | 2000 Dec |
2 |
| 229 |
17018963 | [Aspirin. Acetylsalicylic acid and aspirinlike drugs. A review.]. | 2000 Nov |
1 |
| 230 |
10220459 | Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. | 1999 Apr 27 |
1 |
| 231 |
10381057 | Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. | 1999 Jun |
2 |
| 232 |
10390414 | Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. | 1999 Jul |
1 |
| 233 |
10639016 | COX-2 is not involved in thromboxane biosynthesis by activated human platelets. | 1999 Dec |
6 |
| 234 |
12973429 | Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors. | 1999 Apr-May |
1 |
| 235 |
9515564 | Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. | 1998 Mar 1 |
1 |
| 236 |
9831328 | Anti-inflammatory drugs and their mechanism of action. | 1998 Oct |
1 |
| 237 |
9831331 | Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. | 1998 Oct |
1 |
| 238 |
9263351 | Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. | 1997 |
2 |
| 239 |
9475035 | An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems. | 1997 Oct |
1 |
| 240 |
8718891 | Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2. | 1996 Aug 20 |
1 |
| 241 |
9372101 | Aspirin therapy for cardiovascular disease. | 1996 Sep |
1 |